Joyce van Dodewaard-de Jong

2PUBLICATIONS
10CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Jul 01, 2024
A sub-pharmacological test dose does not predict individual docetaxel exposure in prostate cancer patients.

Marise R Heerma van Voss, Jessica Notohardjo, Joyce van Dodewaard-de Jong

|Feb 25, 2022
Physical Activity Is Associated with Improved Overall Survival among Patients with Metastatic Colorectal Cancer.

Karel C Smit, Jeroen W G Derksen, Geerard L O Beets

Pageof 1

Frequent Collaborators

1 joint publications

Geerard L O Beets

1 joint publications

Mathijs P Hendriks

1 joint publications

Jan N M IJzermans

1 joint publications

Liselot Valkenburg-van Iersel

1 joint publications

Johannes A Wegdam

1 joint publications

Johannes H W de Wilt

1 joint publications

Marise R Heerma van Voss

1 joint publications

Jessica Notohardjo

1 joint publications

Haiko J Bloemendal

1 joint publications

Rob Ter Heine

Frequent Collaborators

1 joint publications

Geerard L O Beets

1 joint publications

Mathijs P Hendriks

1 joint publications

Jan N M IJzermans

1 joint publications

Liselot Valkenburg-van Iersel

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on : Sep 08, 2017

13.3K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

403
See more related videos

Top Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on : Sep 08, 2017

13.3K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

403
See more related videos